
Stéphane Millet
Life sciences production director
Acolad
Stéphane is responsible for developing strategic processes that will drive operational excellence within the Acolad Group and for ensuring the optimization of workflows and localized content for a highly regulated industry. Prior to joining Acolad in 2010, Millet worked as a translator and localization project manager in diverse operational functions. He is also a graduate of the faculty of translation studies, linguistics and cultural studies of the Johannes Gutenberg University in Mainz/Germersheim, Germany.

David Himmelberger
CEO
Health Outcomes Group
David Himmelberger has a Masters Degree in Statistics from Purdue University. In 2010 he was recognized as the Distinguished Science Alumnus by Purdue University. After graduating from Purdue he moved to Stanford University where he was a biostatistician in the School of Medicine, Department of Family, Community and Preventive Medicine, now the Department of Health Policy Research. While at Stanford he worked on numerous projects at the Med School. At Stanford he had the vision about the importance of quality of life as a primary outcome that would be used to approve new medical treatments and to guide patients and physicians in making decisions to select the best treatment option. David left Stanford in 1987 to found Health Outcomes Group, a consultancy focused on measuring health outcomes, especially internationally. One area of expertise at Health Outcomes Group is the translation and linguistic validation of questionnaires for use in multinational clinical trials. David has travelled to more than 70 countries to train linguists to conduct interviews of patients. He was a part of the ISPOR Task Force that created the Guidelines for Translation of Questionnaires Used in Cross-Cultural Research.